Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have type 2 diabetes and a form of kidney disease related to diabetes, shown by certain kidney function test results (confirm specific values with trial site)
- Adults who do not currently have a regular primary care doctor or GP
- Adults for whom a doctor could appropriately start treatment with one or more of three specific kidney-protective medicines — a RAS inhibitor, an SGLT2 inhibitor, or a nonsteroidal mineralocorticoid receptor antagonist (confirm eligibility with trial site)
Who may not be able to join:
- People with low blood pressure (hypotension)
- People with type 1 diabetes
- People who have had an allergic reaction or bad side effects from any of the three medicines being studied in this trial
- People who are already taking all three of the medicines being studied
- People whose blood potassium levels or kidney function results fall outside the ranges required by the trial's guidelines (confirm thresholds with trial site)
- People with a life expectancy of less than one year
- People who are already being looked after by a specialist doctor, such as a kidney specialist (nephrologist) or a hormone/diabetes specialist (endocrinologist)
- People who are not able to give their own informed consent to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 9024886623
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effectiveness of Community Pharmacist-Led Prescribing Algorithms to Improve Guideline-Directed Medical Therapy Use in Diabetic Kidney Disease: The Rx4DKD Randomized Controlled Trial; Effectiveness of Community Pharmacist-Led Prescribing Algorithms to Improve Guideline-Directed Medical Therapy Use in Diabetic Kidney Disease: The Rx4DKD Randomized Controlled Trial
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.